IQI
ANIP icon

Integrated Quantitative Investments’s ANI Pharmaceuticals ANIP Stock Holding History

Integrated Quantitative Investments’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,324
Closed -$1.1M – 389
2026
Q1 		$1.1M Sell
14,324
-11
-0.1% -$859 0.2% 181
2025
Q4 		$1.13M Buy
+14,335
New +$1.24M 0.24% 168
2025
Q1 		– Sell
-4,900
Closed -$271K – 282
2024
Q4 		$271K Buy
+4,900
New +$281K 0.13% 251

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Integrated Quantitative Investments's ANIP Position: Q2 2026 in Review

Integrated Quantitative Investments sold out of ANI Pharmaceuticals (ANIP) in Q2 2026, closing a stake of 14,324 shares — an estimated $1.1M sold.

Integrated Quantitative Investments first reported a position in ANIP in Q4 2024 and held it in 3 quarters. The position peaked at $1.13M in Q4 2025. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Integrated Quantitative Investments reported no remaining ANI Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Integrated Quantitative Investments sold 14,324 ANI Pharmaceuticals shares in Q2 2026, an estimated $1.1M.
  • Integrated Quantitative Investments first reported a position in ANI Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Integrated Quantitative Investments's ANI Pharmaceuticals position peaked at $1.13M in Q4 2025.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.